OncLive® On Air

S10 Ep22: CRC Experts Highlight AE Management and Prevention Strategies for TAS-102/Bevacizumab, Regorafenib, and Fruquintinib

Mar 25, 2024
Ask episode
Chapters
Transcript
Episode notes